Inhibition of ATR acutely sensitizes acute myeloid leukemia cells to nucleoside analogs that target ribonucleotide reductase

S.E. Fordham; H.J. Blair; C.J. Elstob; R. Plummer; Y. Drew; N.J. Curtin; O. Heidenreich; D. Pal; D. Jamieson; C. Park; J. Pollard; S. Fields; P. Milne; G.H. Jackson; H.J. Marr; T. Menne; G.L. Jones; J.M. Allan

doi:10.1182/bloodadvances.2017015214

Inhibition of ATR acutely sensitizes acute myeloid leukemia cells to nucleoside analogs that target ribonucleotide reductase

S.E. Fordham, H.J. Blair, C.J. Elstob, R. Plummer, Y. Drew, N.J. Curtin, O. Heidenreich, D. Pal, D. Jamieson, C. Park, J. Pollard, S. Fields, P. Milne, G.H. Jackson, H.J. Marr, T. Menne, G.L. Jones, J.M. Allan

School of Cellular and Molecular Medicine

Research output: Contribution to journal › Article (Academic Journal) › peer-review

33 Citations (Scopus)

Original language	Undefined/Unknown
Journal	Blood Advances
DOIs	https://doi.org/10.1182/bloodadvances.2017015214
Publication status	Published - 2018

Access to Document

10.1182/bloodadvances.2017015214

Handle.net

Persistent link

Cite this

Fordham, S. E., Blair, H. J., Elstob, C. J., Plummer, R., Drew, Y., Curtin, N. J., Heidenreich, O., Pal, D., Jamieson, D., Park, C., Pollard, J., Fields, S., Milne, P., Jackson, G. H., Marr, H. J., Menne, T., Jones, G. L., & Allan, J. M. (2018). Inhibition of ATR acutely sensitizes acute myeloid leukemia cells to nucleoside analogs that target ribonucleotide reductase. Blood Advances. https://doi.org/10.1182/bloodadvances.2017015214

@article{4f890dd5c27741fba32ef7a32559735a,

title = "Inhibition of ATR acutely sensitizes acute myeloid leukemia cells to nucleoside analogs that target ribonucleotide reductase",

author = "S.E. Fordham and H.J. Blair and C.J. Elstob and R. Plummer and Y. Drew and N.J. Curtin and O. Heidenreich and D. Pal and D. Jamieson and C. Park and J. Pollard and S. Fields and P. Milne and G.H. Jackson and H.J. Marr and T. Menne and G.L. Jones and J.M. Allan",

year = "2018",

doi = "10.1182/bloodadvances.2017015214",

language = "Undefined/Unknown",

journal = "Blood Advances",

issn = "2473-9529",

publisher = "American Society of Hematology",

}

Fordham, SE, Blair, HJ, Elstob, CJ, Plummer, R, Drew, Y, Curtin, NJ, Heidenreich, O, Pal, D, Jamieson, D, Park, C, Pollard, J, Fields, S, Milne, P, Jackson, GH, Marr, HJ, Menne, T, Jones, GL & Allan, JM 2018, 'Inhibition of ATR acutely sensitizes acute myeloid leukemia cells to nucleoside analogs that target ribonucleotide reductase', Blood Advances. https://doi.org/10.1182/bloodadvances.2017015214

TY - JOUR

T1 - Inhibition of ATR acutely sensitizes acute myeloid leukemia cells to nucleoside analogs that target ribonucleotide reductase

AU - Fordham, S.E.

AU - Blair, H.J.

AU - Elstob, C.J.

AU - Plummer, R.

AU - Drew, Y.

AU - Curtin, N.J.

AU - Heidenreich, O.

AU - Pal, D.

AU - Jamieson, D.

AU - Park, C.

AU - Pollard, J.

AU - Fields, S.

AU - Milne, P.

AU - Jackson, G.H.

AU - Marr, H.J.

AU - Menne, T.

AU - Jones, G.L.

AU - Allan, J.M.

PY - 2018

Y1 - 2018

UR - http://www.scopus.com/inward/record.url?eid=2-s2.0-85060321704&partnerID=MN8TOARS

U2 - 10.1182/bloodadvances.2017015214

DO - 10.1182/bloodadvances.2017015214

M3 - Article (Academic Journal)

C2 - 29789314

SN - 2473-9529

JO - Blood Advances

JF - Blood Advances

ER -

Inhibition of ATR acutely sensitizes acute myeloid leukemia cells to nucleoside analogs that target ribonucleotide reductase

Access to Document

Handle.net

Other files and links

Cite this